A potential biomarker for anti-PD-1 immunotherapy

被引：15
|
作者：
Goswami, Sangeeta [1 ]
Basu, Sreyashi [2 ]
Sharma, Padmanee [1 ,2 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA
来源：
NATURE MEDICINE | 2018年 / 24卷 / 02期
关键词：
IMMUNE CHECKPOINT; COMBINED NIVOLUMAB; IPILIMUMAB; CANCER; MELANOMA; THERAPY; MONOCYTES; BLOCKADE;
D O I：
10.1038/nm.4489
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
A recent study identifies an immune cell type known as classical monocytes in the peripheral blood as a potential biomarker for response to anti-PD-1 immune checkpoint therapy in metastatic melanoma.
引用
收藏
页码：123 / 124
页数：2
相关论文
共 50 条
  • [1] A potential biomarker for anti-PD-1 immunotherapy
    Sangeeta Goswami
    Sreyashi Basu
    Padmanee Sharma
    [J]. Nature Medicine, 2018, 24 : 123 - 124
  • [2] Phospho-STAT1 expression as a potential biomarker for anti-PD-1/anti-PD-L1 immunotherapy for breast cancer
    Nakayama, Yuko
    Mimura, Kosaku
    Tamaki, Tomoaki
    Shiraishi, Kensuke
    Kua, Ley-Fang
    Koh, Vivien
    Ohmori, Masato
    Kimura, Ayako
    Inoue, Shingo
    Okayama, Hirokazu
    Suzuki, Yoshiyuki
    Nakazawa, Tadao
    Ichikawa, Daisuke
    Kono, Koji
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 54 (06) : 2030 - 2038
  • [3] Circulating cytokine dynamics as potential biomarker of response to anti-PD-1 immunotherapy in BRAFwt MM patients
    Martinovic, Katarina Mirjacic
    Vuletic, Ana
    Miletic, Nevena Tisma
    Zizak, Irina Besu
    Milovanovic, Jelena
    Matkovic, Suzana
    Jurisic, Vladimir
    [J]. TRANSLATIONAL ONCOLOGY, 2023, 38
  • [4] CD73: A potential biomarker for anti-PD-1 therapy
    Beavis, Paul A.
    Slaney, Clare Y.
    Milenkovski, Nicole
    Henderson, Melissa A.
    Loi, Sherene
    Stagg, John
    Kershaw, Michael H.
    Darcy, Phillip K.
    [J]. ONCOIMMUNOLOGY, 2015, 4 (11):
  • [5] Biomarker prediction to anti-PD-1 immunotherapy by using high dimensional single cell analysis
    Krieg, Carsten
    Nowicka, Malgorzata
    Guglietta, Silvia
    Schindler, Sabrina
    Hartmann, Felix J.
    Weber, Lukas M.
    Dummer, Reinhard
    Robinson, Mark D.
    Levesque, Mitchell P.
    Becher, Burkhard
    [J]. JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [6] Immunotherapy Macrophages hijack anti-PD-1 therapy
    Killock, David
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2017, 14 (07) : 394 - 394
  • [7] Anti-PD-1 monoclonal antibody Cancer immunotherapy
    da Silva, R. Moreira
    [J]. DRUGS OF THE FUTURE, 2014, 39 (01) : 15 - 24
  • [8] Neoadjuvant anti-PD-1 immunotherapy for recurrent glioblastoma
    Mitchell, Dana
    Dey, Mahua
    [J]. TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S577 - S579
  • [9] Precipitation of Autoimmune Diabetes With Anti-PD-1 Immunotherapy
    Hughes, Jing
    Vudattu, Nalini
    Sznol, Mario
    Gettinger, Scott
    Kluger, Harriet
    Lupsa, Beatrice
    Herold, Kevan C.
    [J]. DIABETES CARE, 2015, 38 (04) : e55 - e57
  • [10] Identifying a potential biomarker for anti-PD-1 immunotherapy in patients with advanced stage, surgically-resectable endometrial cancer.
    Fuh, Katherine Cynthia
    Lomonosova, Elena
    Guo, Lei
    Fantl, Wendy
    Pachynski, Russell Kent
    Malkova, Olga
    Oh, Stephen T.
    Hagemann, Andrea R.
    McCourt, Carolyn K.
    Powell, Matthew A.
    Thaker, Premal H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345